What is the potential for thrombopoietic agents in acute leukemia?

Best Practice and Research: Clinical Haematology

Volumn 24, Issue 4, 2011, Pages 553-558

  Kuter, David J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

chemotherapy; leukemia; thrombocytopenia; thrombopoietin

Indexed keywords

AKR 501; ANTINEOPLASTIC AGENT; BUTYZAMIDE; E 5501; ELTROMBOPAG; LGA 4665; MPL ANTIBODY; NIP 004; NIP 022; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT THROMBOPOIETIN; ROMIPLOSTIM; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APHERESIS; ARTICLE; BLOOD DONOR; CANCER CHEMOTHERAPY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; THROMBOCYTOSIS; THROMBOSIS;

EID: 82355194935     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2011.09.002     Document Type: Review

References (22)

1. D.J. Kuter, D.L. Beeler, and R.D. Rosenberg The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production Proc Natl Acad Sci U S A 91 1994 11104 11108 (Pubitemid 24349634)
2. F.J. de Sauvage, P.E. Hass, and S.D. Spencer Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand Nature 369 1994 533 538
3. S. Lok, K. Kaushansky, and R.D. Holly Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo Nature 369 1994 565 568 (Pubitemid 24192525)
4. F. Wendling, E. Maraskovsky, and N. Debili cMpl ligand is a humoral regulator of megakaryocytopoiesis Nature 369 1994 571 574
5. Y. Sohma, H. Akahori, and N. Seki Molecular cloning and chromosomal localization of the human thrombopoietin gene FEBS Lett 353 1994 57 61 (Pubitemid 24312543)
6. T. Kato, A. Matsumoto, and K. Ogami Native thrombopoietin: structure and function Stem Cells 16 1998 322 328 (Pubitemid 28455647)
7. D.J. Kuter Biology and chemistry of thrombopoietic agents Semin Hematol 47 2010 243 248
8. D. Tomita, M. Petrarca, and T. Paine Abstract presented at the American Association of Blood Banks. 50th annual meeting, October 18-22, 1997 Transfusion 37 1997 9s
9. S. Nomura, K. Dan, and T. Hotta Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura Blood 100 2002 728 730 (Pubitemid 34761148)
10. D.J. Kuter The use of PEG-rhuMGDF in platelet apheresis Stem Cells 16 Suppl. 2 1998 231 242
11. R.L. Basser, J.E. Rasko, and K. Clarke Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer Blood 89 1997 3118 3128
12. E. Archimbaud, O.G. Ottmann, and J.A. Yin A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia Blood 94 1999 3694 3701
13. K. Geissler, J.A. Yin, and A. Ganser Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia-a randomized, placebo-controlled, double-blind safety and efficacy study Ann Hematol 82 2003 677 683 (Pubitemid 37455706)
14. S.H. Bernstein, W.J. Jusko, and W. Krzyzanski Pharmacodynamic modeling of thrombopoietin, platelet, and megakaryocyte dynamics in patients with acute myeloid leukemia undergoing dose intensive chemotherapy J Clin Pharmacol 42 2002 501 511 (Pubitemid 34438549)
15. C.A. Schiffer, K. Miller, and R.A. Larson A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia Blood 95 2000 2530 2535 (Pubitemid 30210530)
16. J. Glaspy, J. Vredenburgh, and G.D. Demetri Effect of PEGylated recombinant megakaryocyte growth and development factor (PEG-rHuMGDF) before high dose chemotherapy with peripheral blood progenitor cell (PBPC) support Blood 90 1997 580a [abstr]
17. K. Usuki, T. Tahara, and S. Iki Serum thrombopoietin level in various hematological diseases Stem Cells 14 1996 558 565 (Pubitemid 26322116)
18. C. Gonen, I.C. Haznedaroglu, and S. Aksu Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia Platelets 16 2005 31 37 (Pubitemid 40115944)
19. K. Geissler, E. Kabrna, and S. Stengg Recombinant human megakaryocyte growth and development factor increases levels of circulating haemopoietic progenitor cells post chemotherapy in patients with acute myeloid leukaemia Br J Haematol 102 1998 535 543 (Pubitemid 28346598)
20. G. Molineux The development of romiplostim for patients with immune thrombocytopenia Ann N Y Acad Sci 1222 2011 55 63
21. J.A. Erhardt, C.L. Erickson-Miller, and M. Aivado Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function Exp Hematol 37 2009 1030 1037
22. C.L. Erickson-Miller, E. Delorme, and S.S. Tian Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist Stem Cells 27 2009 424 430